Here's the live share price of Hester Biosciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Hester Biosciences | 1.55 | -0.17 | -6.11 | -16.70 | -11.13 | -5.68 | -6.13 |
| Sun Pharmaceutical Industries | -2.36 | -8.73 | -4.73 | -0.97 | -1.95 | 17.94 | 21.73 |
| Divi's Laboratories | 4.23 | -4.18 | -5.91 | -5.76 | 9.16 | 28.02 | 10.04 |
| Torrent Pharmaceuticals | 4.43 | -5.88 | 5.51 | 17.77 | 33.20 | 38.26 | 26.66 |
| Lupin | 2.46 | -0.34 | 6.53 | 19.04 | 18.47 | 52.09 | 17.41 |
| Dr. Reddy's Laboratories | 1.18 | -6.23 | 1.34 | -2.59 | 11.08 | 8.99 | 4.31 |
| Cipla | 3.03 | -7.76 | -16.13 | -21.26 | -15.96 | 10.89 | 6.37 |
| Zydus Lifesciences | 5.87 | -0.86 | 2.23 | -7.90 | 5.38 | 22.60 | 12.85 |
| Mankind Pharma | 4.38 | -6.83 | -6.37 | -15.20 | -11.33 | 13.55 | 7.92 |
| Aurobindo Pharma | 1.13 | 5.07 | 15.21 | 19.49 | 24.80 | 35.70 | 8.08 |
| Alkem Laboratories | 3.48 | -3.19 | -7.30 | -0.24 | 11.46 | 17.29 | 14.66 |
| Glenmark Pharmaceuticals | 3.21 | -3.00 | 7.10 | 11.46 | 56.91 | 64.24 | 34.10 |
| Laurus Labs | 4.95 | 5.64 | 5.14 | 24.98 | 80.80 | 53.31 | 21.36 |
| Biocon | -1.12 | -11.89 | -6.30 | -1.22 | 10.12 | 17.38 | -2.91 |
| Abbott India | -1.47 | -3.77 | -8.88 | -14.20 | -12.47 | 4.32 | 11.45 |
| Anthem Biosciences | 12.22 | 10.75 | 20.14 | -7.27 | 1.60 | 0.53 | 0.32 |
| GlaxoSmithKline Pharmaceuticals | 3.44 | -4.08 | -0.36 | -13.53 | -13.00 | 22.77 | 10.45 |
| Ipca Laboratories | -1.95 | -2.23 | -4.67 | 9.20 | 9.41 | 20.45 | 6.23 |
| Ajanta Pharma | 0.11 | -6.73 | 2.35 | 14.94 | 9.02 | 29.49 | 19.64 |
| J B Chemicals & Pharmaceuticals | 2.43 | -5.45 | 6.78 | 19.66 | 27.27 | 25.08 | 26.91 |
Over the last one year, Hester Biosciences has declined 11.13% compared to peers like Sun Pharmaceutical Industries (-1.95%), Divi's Laboratories (9.16%), Torrent Pharmaceuticals (33.20%). From a 5 year perspective, Hester Biosciences has underperformed peers relative to Sun Pharmaceutical Industries (21.73%) and Divi's Laboratories (10.04%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,379.18 | 1,408.59 |
| 10 | 1,368.08 | 1,399.39 |
| 20 | 1,403.34 | 1,411.62 |
| 50 | 1,471.88 | 1,461.83 |
| 100 | 1,536.14 | 1,534.53 |
| 200 | 1,706.25 | 1,645.9 |
In the latest quarter, Hester Biosciences remained same as its previous close in promoter holding, while DII stake decreased to 0.00%, FII holding fell to 0.38%, and public shareholding moved up to 45.88% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Apr 08, 2026, 04:14 PM IST IST | Hester Biosciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Apr 03, 2026, 08:43 PM IST IST | Hester Biosciences - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A |
| Mar 20, 2026, 08:59 PM IST IST | Hester Biosciences - Announcement under Regulation 30 (LODR)-Credit Rating |
| Mar 11, 2026, 04:47 PM IST IST | Hester Biosciences - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment |
| Mar 11, 2026, 04:43 PM IST IST | Hester Biosciences - Board Meeting Outcome for Outcome Of Board Meeting |
Hester Biosciences Ltd. is a Public Limited Listed company incorporated on 29/04/1987 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L99999GJ1987PLC022333 and registration number is 022333. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 286.47 Cr. and Equity Capital is Rs. 8.51 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Hester Biosciences is ₹1,450.00 as on Apr 10, 2026.
The Hester Biosciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Hester Biosciences is ₹1,233.50 Cr as on Apr 10, 2026.
Today’s highest and lowest price of Hester Biosciences are ₹1,453.00 and ₹1,433.75.
The 52-week high/low is the highest and lowest price at which Hester Biosciences stock has traded in the past 52-week or nearly a year. The 52-week high of Hester Biosciences is ₹2,347.70 and 52-week low of Hester Biosciences is ₹1,250.95 as on Apr 10, 2026.
The Hester Biosciences has shown returns of 2.25% over the past day, -0.17% for the past month, -6.11% over 3 months, -11.13% over 1 year, -5.68% across 3 years, and -6.13% over 5 years.
P/E ratio of and PB ratio of Hester Biosciences are 30.12 and 3.57 on Apr 10, 2026. While the company gives a dividend yield of 0.48 per annum.